LyondellBasell Industries (LYB) Earnings Date & Reports

Key Takeaways

• LyondellBasell reported third quarter 2026 net income of $758 million, or $2.32 per diluted share, a sharp swing from a net loss of $890 million in the prior-year period.
• Excluding identified items, net income was $828 million, or $2.54 per diluted share, while EBITDA (earnings before interest, taxes, depreciation, and amortization) excluding identified items reached $1.5 billion.
• Sales and other operating revenues totaled $8.499 billion, and both GAAP and adjusted earnings per share came in below the consensus analyst estimate of $2.98.
• The company generated $1.7 billion in cash from operating activities and ended the quarter with $3.2 billion in cash and $7.7 billion in available liquidity.
• LyondellBasell repaid its €500 million note maturity and returned $224 million to shareholders through dividends during the quarter.
• Get more details on the ticker's Major News, Today's Price Move, Price Targets, and Forecast on additional pages.
• Explore Trending AI Robots to discover AI-driven trading strategies across the market.

Earnings Context and Why It Matters

LyondellBasell's third quarter results mark a meaningful recovery from the prior-year period, when the company posted a net loss of $890 million amid weak chemical demand and restructuring charges. This quarter's return to profitability reflects the resilience of the company's diversified, cost-advantaged portfolio, even as lower polymer and olefin prices pressured margins in its Olefins & Polyolefins (O&P) segments. For investors, the report is a key gauge of commodity chemical demand, feedstock cost trends, and the progress of LyondellBasell's $500 million Cash Improvement Plan. The results also highlight the company's ability to convert earnings into cash, a critical signal given the capital-intensive nature of the chemicals industry and its importance to sustaining the dividend.

Reported Results

For the quarter ended September 30, 2026, LyondellBasell reported net income of $758 million, or $2.32 per diluted share, compared with a net loss of $890 million, or $2.77 per diluted share, in the third quarter of 2025. Excluding identified items, net income was $828 million, or $2.54 per diluted share, with EBITDA excluding identified items of $1.5 billion. Sales and other operating revenues were $8.499 billion, up from $7.727 billion a year earlier but below the consensus estimate of roughly $8.87 billion.

Both GAAP and adjusted earnings per share fell short of the analyst estimate of $2.98. The shortfall was driven in part by identified items totaling about $70 million net of tax, including closure costs related to a European propylene oxide joint venture. Profitability in the O&P segments declined sequentially on lower polymer and olefin prices, while the Intermediates & Derivatives segment delivered materially higher profitability on stronger oxyfuels margins.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. If you are looking to streamline your research and surface actionable ideas across sectors like chemicals and beyond, the AI Screener is a practical place to start.

Market Reaction and Investor Sentiment

The market's response to LyondellBasell's report centered on the earnings miss relative to consensus, with both revenue and adjusted EPS landing below expectations. While the year-over-year swing to profitability and the strong cash conversion were positives, the sequential decline in O&P profitability and lower polymer prices weighed on sentiment. Investors also weighed the company's diversified portfolio, where record Intermediates & Derivatives performance partially offset weakness elsewhere. The results reinforced a cautious view on near-term commodity chemical margins, even as the company's balance sheet strength and disciplined capital allocation provided a supportive backdrop.

Forward Outlook and Key Factors to Monitor

Looking ahead, LyondellBasell provided fourth quarter operating rate guidance of 85% for North American O&P assets, 60% for European O&P assets, and 75% for Intermediates & Derivatives assets. These levels reflect a continued effort to align production with demand in a dynamic pricing environment.

Several factors will be important to watch in the coming quarters. Polymer and olefin prices remain a central swing factor, with U.S. domestic polyethylene prices having risen in September and additional industry price increases announced for October and November. However, rising feedstock costs could partially offset those gains. The strength of oxyfuels margins and global supply conditions in the Intermediates & Derivatives segment will also be closely monitored.

On the cost side, investors should track progress on the $500 million Cash Improvement Plan and the company's workforce reductions, which have already reduced headcount by roughly 18% compared with the beginning of last year. With an investment-grade balance sheet, $3.2 billion in cash, and $7.7 billion in liquidity, LyondellBasell retains flexibility to fund its sustaining capital program, pursue selective growth, and maintain shareholder returns across the cycle.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations